Ad
related to: high dose vitamin d pancreatic cancer treatment
Search results
Results from the WOW.Com Content Network
[33] [32] According to the U.S. Food and Drug Administration (FDA), high-dose vitamin C (such as intravenous ascorbic acid therapy) has not been approved as a treatment for cancer or any other medical condition. [2] There many been multiple studies devoted to investigating the medicinal properties of ascorbic acid.
Vitamin D toxicity, or hypervitaminosis D, is the toxic state of an excess of vitamin D. The normal range for blood concentration of 25-hydroxyvitamin D in adults is 20 to 50 nanograms per milliliter (ng/mL).
A review of clinical trials in the treatment of colds with small and large doses of Vitamin C has established that there is no evidence that it decreases the incidence of common colds. [28] After 33 years of research, it is still not established whether vitamin C can be used as a treatment for cancer. [29]
Some vitamins such as vitamins ADEK are toxic in high doses, [69] including niacin (B 3), [70] cholecalciferol (D) [71] and tocopherol (E). [72] The view of the medical community is that there is no evidence for the efficacy of Orthomolecular medicine as a treatment for cancer, [ 6 ] and that high vitamin doses may – on the contrary ...
Treatment involves an initial high-dosage treatment phase until the required serum levels are reached, followed by the maintenance of the acquired levels. The lower the 25(OH)D serum concentration is before treatment, the higher the dosage that is needed to quickly reach an acceptable serum level. [63]
The Office of Cancer Complementary and Alternative Medicine (OCCAM) is an office of the National Cancer Institute (NCI) in the Division of Cancer Treatment and Diagnosis. . OCCAM was founded in 1998 and is responsible for NCI's research agenda in pseudoscientific complementary and alternative medicine (CAM), as it relates to cancer prevention, diagnosis, treatment, and symptom management
High-dose chemotherapy (HDC) is a regimen of chemotherapy medicines given at larger dosages. This therapeutic strategy is used to treat some cancers, especially those that are aggressive or have a high chance of coming back. With increased doses of chemotherapy chemicals administered to the body, HDC seeks to optimize the death of cancer cells.
While serum low 25-hydroxyvitamin D status has been associated with a higher risk of cancer in observational studies, [101] [102] [103] the general conclusion is that there is insufficient evidence for an effect of vitamin D supplementation on the risk of cancer, [2] [104] [105] although there is some evidence for reduction in cancer mortality.
Ad
related to: high dose vitamin d pancreatic cancer treatment